摘要 |
<p>Disclosed are an anti-angiogenic compound, represented by Chemical Formula I, or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutically acceptable composition including the same. Because the compound of Chemical Formular I potently suppresses the angiogenesis, the compound of Chemical Formula I is applicable to the prevention and treatment of diseases caused by aberrant activity of vascular endothelial growth factor, and available as an anti-angiogenic agent.</p> |
申请人 |
BORYUNG PHARMACEUTICAL CO., LTD. |
发明人 |
KIM, JI HAN;KIM, JE HAK;LEE, JOON KWANG;JUNG, HAHN-SUN;HAN, NAM SEOK;PARK, YONG;KANG, SEUNG-HOON;JEONG, HEE JIN;LEE, KYUNG-TAE;CHOI, HYE EUN;CHI, YONG HA;LEE, JOO HAN;PAIK, SOO HEUI |